DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/9z6crw/otitis_externa) has announced the addition of the "Otitis Externa Global Clinical Trials Review, H2, 2015" report to their offering.
"Otitis Externa Global Clinical Trials Review, H2, 2015" provides an overview of the Otitis Externa clinical trials scenario. This report provides top line data relating to the clinical trials on Otitis Externa.
The report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe.
The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. The report also provides prominent drugs for in-progress trials (based on number of ongoing trials).
The report enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Clinical Trial Overview of Top Companies
- Oticpharma Ltd
- Novum Pharmaceutical Research Services, Inc.
- Novartis AG
- MerLion Pharmaceuticals Pte Ltd
- Foresight Biotherapeutics, Inc.
- Farmoquimica S/A
- Alcon, Inc.
- Alcon Pharma GmbH
- AmpliPhi Biosciences Corporation
- Acorus Therapeutics Ltd
Clinical Trial Overview of Top Institutes / Government
- Babol University of Medical Sciences
- Department of Health, UK
- Fairfax Hospital
- James Cook University
- NHS Trusts Clinical Trials
- North Bristol NHS Trust
- Saitama Medical University
- Sieff Medical Center
For more information visit http://www.researchandmarkets.com/research/9z6crw/otitis_externa
